Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing, China.
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Cancer Sci. 2023 Sep;114(9):3708-3718. doi: 10.1111/cas.15889. Epub 2023 Jun 18.
Malignant transformation (MT) of low-grade gliomas (LGGs) to a higher-grade variant seems inevitable, yet it remains unclear which LGG patients will progress to grade 3 or even directly to grade 4 after receiving a long course of treatment. To elucidate this, we conducted a retrospective cohort study based on 229 adults with recurrent LGG. Our study aimed to disclose the characteristics of different MT patterns and to build predictive models for patients with LGG. Patients were allocated into group 2-2 (n = 81, 35.4%), group 2-3 (n = 91, 39.7%), and group 2-4 (n = 57, 24.9%), based on their MT patterns. Patients who underwent MT showed lower Karnofsky performance scale (KPS) scores, larger tumor sizes, smaller extents of resection (EOR), higher Ki-67 indices, lower rates of 1p/19q codeletion, but higher rates of subventricular involvement, radiotherapy, chemotherapy, astrocytoma, and post-progression enhancement (PPE) compared with those in group 2-2 (p < 0.01). On multivariate logistic regression, 1p/19q codeletion, Ki-67 index, radiotherapy, EOR, and KPS score were independently associated with MT (p < 0.05). Survival analyses demonstrated that patients in group 2-2 had the longest survival, followed by group 2-3 and then group 2-4 (p < 0.0001). Based on these independent parameters, we constructed a nomogram model that exhibited superior potential (sensitivity: 0.864, specificity: 0.814, and accuracy: 0.843) compared with PPE in early prediction of MT. Combining the factors of 1p/19q codeletion, Ki-67 index, radiotherapy, EOR, and KPS score that were presented at initial diagnosis could precisely forecast the subsequent MT patterns of patients with LGG.
低级别胶质瘤(LGG)向高级别变异的恶性转化(MT)似乎不可避免,但仍不清楚哪些 LGG 患者在接受长期治疗后会进展为 3 级甚至直接进展为 4 级。为了阐明这一点,我们对 229 例复发性 LGG 成人患者进行了回顾性队列研究。我们的研究旨在揭示不同 MT 模式的特征,并为 LGG 患者建立预测模型。根据 MT 模式,患者被分为 2-2 组(n=81,35.4%)、2-3 组(n=91,39.7%)和 2-4 组(n=57,24.9%)。与 2-2 组相比,MT 患者的卡氏功能状态评分(KPS)较低,肿瘤较大,切除范围(EOR)较小,Ki-67 指数较高,1p/19q 缺失率较低,但脑室下侵犯、放疗、化疗、星形细胞瘤和进展后增强(PPE)的发生率较高(p<0.01)。多变量逻辑回归分析显示,1p/19q 缺失、Ki-67 指数、放疗、EOR 和 KPS 评分与 MT 独立相关(p<0.05)。生存分析表明,2-2 组患者的生存时间最长,其次是 2-3 组,然后是 2-4 组(p<0.0001)。基于这些独立参数,我们构建了一个列线图模型,与早期 PPE 相比,该模型具有更好的预测能力(敏感性:0.864,特异性:0.814,准确性:0.843)。结合初诊时出现的 1p/19q 缺失、Ki-67 指数、放疗、EOR 和 KPS 评分等因素,可以准确预测 LGG 患者后续 MT 模式。